The heart-pounding news regarding the preparation of COVID-19 vaccine which has been awaited anxiously for the whole year is finally here with a victorious outcome. Well, the developers Pfizer and BioNTech depict this day as a long-awaited blessing to mankind.
Great news!
And because of the @realDonaldTrump administration’s deal with Pfizer, 600 MILLION doses of this vaccine can be made available for Americans if approved. https://t.co/0EyvPFzBKS
— Ronna McDaniel (@GOPChairwoman) November 9, 2020
Many scientists in various countries have been working tirelessly on this COVID-19 vaccine since the breakout of this deadly disease. In the wake of saving innocent lives, 43,500 people were tested by the scientists and the analysis showed a much better performance. People who were tested started recovering and became healthy. As per the manufacturers, the vaccine applied to thousands of people showed 90% effective results.
Read Here: Donald Trump declares himself immune to Covid-19
The vaccine would be available in the market by the end of the month. All these endeavours are being done on an emergency basis. Still, a plethora of hurdles are standing in the way leading to a normal life. However, the announcement of this news has produced a beam of hope in the darkest era. Normality till spring season is expected with the accessibility of this immunity serum.
Sir John Bell, the most senior professor at Oxford University stated that “I am probably the first guy to say that, but I will say that with some confidence.”
Statements of seniors about COVID-19 vaccine
On this occasion of huge achievement, the chairman of Pfizer Dr Albert Bourla said that “Today is a great day for science and humanity. The first set of results from our phase 3 Covid-19 vaccine trial provides the initial evidence of our vaccine’s ability to prevent Covid-19.”
Dr Albeta further stated that “We are reaching this critical milestone in our vaccine development programme at a time when the world needs it most with infection rates setting new records, hospitals nearing over-capacity and economies struggling to reopen.”
In the prevailing times, the inoculation would accelerate the recovery rate in the world. The manufacturing company Pfizer and BioNtech believe that 50 million doses would be supplied by the end of this year, whereas, the supply would be enhanced by 1.3 billion doses by the end of 2021.
Read Here: Italy tightens coronavirus rules after Covid-19 cases surge
Professor Horby who runs the vaccine trials at Oxford University said “This news made me smile from ear to ear,” he said. “It is a relief to see such positive results on this vaccine and bodes well for Covid-19 vaccines in general. Of course, we need to see more detail and await the final results, and there is a long, long way to go before vaccines will start to make a real difference, but this feels to me like a watershed moment.”
Hopefully, with the prayers and blessings from the entire mankind, the experts would soon be able to get 100% fruitful results of this COVID-19 vaccine and would save the world from this pandemic.